Search for: "*du. S. v. Rider" Results 1 - 14 of 14
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jul 2019, 7:03 am by Larry
Today, riders are tackling the 14th stage of the Tour du France, climbing the col du Tormalet in the Pyrenees toward the village of Bareges. [read post]
23 Sep 2013, 4:00 am by Administrator
In this week’s case (Khodadoost v. [read post]
24 May 2010, 12:56 pm by David Kopel
Most of Russell’s paper concentrates on Simkins’ career at UT, as well as the 1954 decision (five weeks after Brown v. [read post]
15 Jan 2024, 7:31 pm by Peter S. Lubin and Patrick Austermuehle
Cont’l Du Page Acura, 236 Ill.App.3d 891, 904 (2nd Dist. 1992) ($5,000 in punitive damages for concealing rebuilt wreck with $400 in actual damages); Crowder v. [read post]
22 Apr 2013, 4:00 am by Administrator
Rule of LawSabey v. [read post]
27 Nov 2023, 2:36 am by Eleonora Rosati
Court of Appeal finds no reason to swipe right in MATCH v MUZMATCH online dating disputeMatch Group, LLC v Muzmatch Ltd [2023] EWCA Civ 454 (April 2023)“MATCH” is hardly a distinctive trade mark for an online dating, aka matchmaking, service. [read post]
12 Jul 2010, 5:46 am by Marie Louise
Edwards Lifesciences AG v Cook Biotech Incorporated (IPKat) England’s new shirt sponsors? [read post]
29 Jun 2018, 11:53 am by Edith Roberts
The dissent in Patel compared Willett’s approach to that taken in Lochner v. [read post]
27 Feb 2009, 7:00 am
– Address to Joint Session of Congress 24 Feb (Securing Innovation) (Securing Innovation)   US Patents – Decisions Supreme Court rejects Federal Trade Commission’s bid to revive battle with Rambus (Law360) (ContentAgenda) (Hal Wegner) Supreme Court declines petition to review Singleton v Volkswagon regarding transfer of venue under 28 USC §1404(a) (Patent Prospector) (Hal Wegner) CAFC: Affidavit evidence to rebut KSR obviousness:… [read post]
23 May 2008, 1:03 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
19 Mar 2022, 2:09 pm by admin
The FDA’s M7 Guidance observes that “[s]tandard risk assessments of known carcinogens assume that cancer risk increases as a function of cumulative dose. [read post]